Sabra Health Care REIT (SBRA) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Sabra Health Care REIT · Real Estate · ref. ETF XLRE · 71 calls · price $20.7
🏆JPI 2026 portfoliosSee tracking →
What the company does: Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.

📈 Sabra Health Care REIT (SBRA) stock price

$20.7+7.2% over range
Aug 28, 25low $17.23 · high $22.39Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
30% recommend buying · 10 analysts
📊 JPI status : Sabra Health Care REIT is no longer in our current JPI rankings, but appeared in the past (2021) — its upside may be behind it. See the stocks picked in 2021 →

🎯 SBRA price target & analyst consensusprice $20.70

The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$25+20.8%
Median target · of 9 targets$22+6.3%
Lowest target · 2 firms of 9$19-8.2%
Current price$20.7
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 778% $21 ↔ $25
Below 222% $19
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Baird64% of its targets hit on this sector (55 calls tested). It aims for $23 (+11 %), call made on July 23, 2026, maturing on July 23, 2027 (36 d ago).

The 3 reliable analysts $23+11 %
The 6 other firms $21.50+3.9 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $23 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy330%
Hold770%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Sabra Health Care REIT? The JPI assistant answers using our backtest data.

💰 Sabra Health Care REIT dividend: yield, history & growth › open the full page

6.10%annual yield
That's ~$1.20 per share per year.

📈 Sabra Health Care REIT fundamentals: valuation, margins & growth › open the full page

P/E 79.6Net margin 7.6 %Revenue growth +25.3 %Fairly valued

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. -12 %
2023
Rev +4%
2024
Rev +9%Profit +821%
2025
Rev +10%Profit +23%

🔎 Detailed analyses

🏛️ Which US Congress members hold Sabra Health Care REIT (SBRA)?

2 Congress members have disclosed SBRA buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Christopher Jacobs · 21%Daniel Goldman · 25%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on SBRA

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Citigroup  100% +19.4% 2
Jefferies  80% +14.0% 10
Truist Securities  75% +11.9% 4
Stifel  65% +8.4% 17
Raymond James  50% -1.1% 4
JMP Securities 50% -6.4% 8
Mizuho  43% -4.6% 7
Barclays  38% -9.2% 8
B of A Securities  33% -1.7% 6
BMO Capital  0% -18.7% 2
See the other 1 firms
Wells Fargo  0% -22.3% 2

📊 What $1,000 invested in Sabra Health Care REIT would be worth › open the full page

In short — $1,000 invested in Sabra Health Care REIT 10 years ago would be worth $964 today, i.e. 0%/yr on average. Best year: 2019 (+29%), worst: 2017 (-23%). Price performance, excluding dividends.

If I'd invested $1,000 in Sabra Health Care REIT

InvestmentWorth todayGain
1 years ago$1,126+13%
3 years ago$1,570+57%
5 years ago$1,123+12%
→ See Sabra Health Care REIT's full return history + gain calculator

Return by year (Sabra Health Care REIT)

YearReturn$1,000 invested at year start
2026 (YTD)+3%$1,030 (+3%)
2025+9%$1,126 (+13%)
2024+21%$1,367 (+37%)
→ See Sabra Health Care REIT's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Sabra Health Care REIT

Loading news…

📋 All analyst calls on SBRA

Raymond James 
Aug 6, 26
■ Market Perform neutral · not a buy
🎯 on SBRA : no call matured yet · 📊 on Real estate : 52% · +3.8% (175 calls)
in progress (365j)
matures : Aug 6, 27
Baird 
Jul 22, 26
■ Neutral neutral · not a buy · 🎯$23
Price at call : $22.03 — gap to target +4%
Today : $20.7 — gap to target +11%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 50.9% · +3.1% (55 calls)
in progress (365j)
matures : Jul 22, 27
▲ Buy · 🎯$24
Price at call : $22.03 — upside +9%
Today : $20.7 — upside +16%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Jul 22, 27
Citizens
Jul 22, 26
▲ Market Outperform · 🎯$25
Price at call : $22.03 — upside +13%
Today : $20.7 — upside +21%
🎯 on SBRA : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 22, 27
UBS 
Jul 8, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $19.88 — gap to target +6%
Today : $20.7 — gap to target +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 53.3% · +9.2% (30 calls)
in progress (365j)
matures : Jul 8, 27
▲ Buy · 🎯$22
Price at call : $20.03 — upside +10%
Today : $20.7 — upside +6%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Jul 8, 27
Barclays 
Jul 7, 26
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $20.06 — gap to target +5%
Today : $20.7 — gap to target +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 49.5% · -1.2% (109 calls)
in progress (365j)
matures : Jul 7, 27
Citigroup 
Jun 23, 26
■ Neutral neutral · not a buy · 🎯$19
Price at call : $19.09 — gap to target -0%
Today : $20.7 — gap to target -8%
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 45.5% · -9.2% (44 calls)
in progress (365j)
matures : Jun 23, 27
See the other 63 calls, newest to oldest
Scotiabank 
Jun 18, 26
■ Sector Perform neutral · not a buy · 🎯$19
Price at call : $18.27 — gap to target +4%
Today : $20.7 — gap to target -8%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : Jun 18, 27
Wells Fargo 
Jun 1, 26
▲ Overweight · 🎯$23
Price at call : $18.57 — upside +24%
Today : $20.7 — upside +11%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Jun 1, 27
Scotiabank 
May 21, 26
■ Sector Perform neutral · not a buy · 🎯$22
Price at call : $20.72 — gap to target +6%
Today : $20.7 — gap to target +6%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : May 21, 27
UBS 
May 13, 26
■ Neutral neutral · not a buy · 🎯$22
Price at call : $21.2 — gap to target +4%
Today : $20.7 — gap to target +6%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 53.3% · +9.2% (30 calls)
in progress (365j)
matures : May 13, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $20.68 — gap to target +6%
Today : $20.7 — gap to target +6%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 62.5% · +10.2% (8 calls)
in progress (365j)
matures : May 11, 27
Wells Fargo 
Mar 26, 26
▲ Overweight · 🎯$22
Price at call : $19.61 — upside +12%
Today : $20.7 — upside +6%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Mar 26, 27
■ Hold neutral · not a buy · 🎯$22
Price at call : $20.91 — gap to target +5%
Today : $20.7 — gap to target +6%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Mar 13, 27
Scotiabank 
Mar 2, 26
■ Sector Perform neutral · not a buy · 🎯$21
Price at call : $20.42 — gap to target +3%
Today : $20.7 — gap to target +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : Mar 2, 27
UBS 
Feb 19, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $19.93 — gap to target +5%
Today : $20.7 — gap to target +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 53.3% · +9.2% (30 calls)
in progress (365j)
matures : Feb 19, 27
Citigroup 
Feb 18, 26
▲ Buy · 🎯$24
Price at call : $20.02 — upside +20%
Today : $20.7 — upside +16%
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 45.5% · -9.2% (44 calls)
in progress (365j)
matures : Feb 18, 27
Citizens
Feb 18, 26
▲ Market Outperform · 🎯$23
Price at call : $20.03 — upside +15%
Today : $20.7 — upside +11%
🎯 on SBRA : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Feb 18, 27
■ Neutral neutral · not a buy · 🎯$21
Price at call : $20.59 — gap to target +2%
Today : $20.7 — gap to target +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 62.5% · +10.2% (8 calls)
in progress (365j)
matures : Feb 17, 27
■ Hold neutral · not a buy · 🎯$21
Price at call : $19.21 — gap to target +9%
Today : $20.7 — gap to target +1%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Jan 20, 27
Wells Fargo 
Nov 25, 25
▲ Overweight · 🎯$21
Price at call : $19.34 — upside +9%
Today : $20.7 — upside +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Nov 25, 26
UBS 
Nov 18, 25
■ Neutral neutral · not a buy · 🎯$20
Price at call : $18.81 — gap to target +6%
Today : $20.7 — gap to target -3%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 53.3% · +9.2% (30 calls)
in progress (365j)
matures : Nov 18, 26
Wells Fargo 
Oct 21, 25
▲ Overweight · 🎯$20
Price at call : $18.11 — upside +10%
Today : $20.7 — upside -3%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Oct 21, 26
■ Neutral neutral · not a buy · 🎯$20
Price at call : $18.26 — gap to target +10%
Today : $20.7 — gap to target -3%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 62.5% · +10.2% (8 calls)
in progress (365j)
matures : Oct 1, 26
■ Hold neutral · not a buy · 🎯$20
Price at call : $19 — gap to target +5%
Today : $20.7 — gap to target -3%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Sep 3, 26
Wells Fargo 
Aug 27, 25
▲ Overweight · 🎯$21
Price at call : $19.31 — upside +9%
Today : $20.7 — upside +1%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Aug 27, 26
BMO Capital 
Aug 25, 25
■ Market Perform neutral · not a buy · 🎯$22
Price at call : $19.19 — gap to target +15%
Today : $20.7 — gap to target +6%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 42.9% · +0.6% (42 calls)
in progress (365j)
matures : Aug 25, 26
▲ Market Outperform · 🎯$22
Price at call : $18.68 — upside +18%
Today : $20.7 — upside +6%
Expected +18% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 100% (2 calls matureds) · 📊 unranked overall
+12.6%
stock +13% · XLRE +8%
matured Aug 6, 26
Scotiabank 
Jun 23, 25
■ Sector Perform neutral · not a buy · 🎯$20
Price at call : $18.53 — gap to target +8%
Today : $20.7 — gap to target -3%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : Jun 23, 26
Scotiabank 
May 12, 25
■ Sector Perform neutral · not a buy · 🎯$19
Price at call : $17.75 — gap to target +7%
Today : $20.7 — gap to target -8%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : May 12, 26
■ Hold neutral · not a buy · 🎯$18
Price at call : $17.61 — gap to target +2%
Today : $20.7 — gap to target -13%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Mar 18, 26
▲ Market Outperform · 🎯$20
Price at call : $15.88 — upside +26%
Today : $20.7 — upside -3%
Expected +26% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 100% (1 call matured) · 📊 unranked overall
+28.6%
stock +29% · XLRE +3%
matured Feb 21, 26
■ Hold neutral · not a buy · 🎯$17
Price at call : $17.05 — gap to target -0%
Today : $20.7 — gap to target -18%
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
in progress (365j)
matures : Jan 17, 26
▲ Market Outperform · 🎯$20
Price at call : $17.18 — upside +16%
Today : $20.7 — upside -3%
Expected +16% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 100% (2 calls matureds) · 📊 unranked overall
+14.1%
stock +14% · XLRE +1%
matured Jan 7, 26
Mizuho 
Dec 5, 24
■ Neutral neutral · not a buy · 🎯$20
Price at call : $18.26 — gap to target +10%
Today : $20.7 — gap to target -3%
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 48.4% · -1.4% (64 calls)
in progress (365j)
matures : Dec 5, 25
Scotiabank 
Oct 11, 24
■ Sector Perform neutral · not a buy · 🎯$18
Price at call : $18.18 — gap to target -1%
Today : $20.7 — gap to target -13%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : Oct 11, 25
Citigroup 
Sep 13, 24
▲ Buy · 🎯$20
Price at call : $18.59 — upside +8%
Today : $20.7 — upside -3%
Expected +8% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 45.5% · -9.2% (44 calls)
+3.2%
stock +3% · XLRE -6%
matured Sep 13, 25
▲ Buy · 🎯$18
Price at call : $17.44 — upside +3%
Today : $20.7 — upside -13%
Expected +3% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
+9.1%
stock +9% · XLRE -3%
matured Sep 4, 25
Scotiabank 
Aug 26, 24
■ Sector Perform neutral · not a buy · 🎯$17
Price at call : $16.78 — gap to target +1%
Today : $20.7 — gap to target -18%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : Aug 26, 25
▲ Buy · 🎯$16
Price at call : $15.12 — upside +6%
Today : $20.7 — upside -23%
Expected +6% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 100% (2 calls matureds) · 📊 on Real estate : 58% · +9.5% (81 calls)
+20.8%
stock +21% · XLRE +8%
matured Jun 27, 25
Scotiabank 
May 15, 24
■ Sector Perform neutral · not a buy · 🎯$15
Price at call : $14.48 — gap to target +4%
Today : $20.7 — gap to target -28%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 31.2% · -6.2% (16 calls)
in progress (365j)
matures : May 15, 25
Deutsche Bank 
Jan 30, 24
▲ Buy · 🎯$21
Price at call : $13.58 — upside +55%
Today : $20.7 — upside +1%
Expected +55% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 58.8% · +3.6% (51 calls)
+22.1%
stock +22% · XLRE +7%
matured Jan 29, 25
Mizuho 
Jan 3, 24
▲ Buy · 🎯$17
Price at call : $14.02 — upside +21%
Today : $20.7 — upside -18%
Expected +21% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 48.4% · -1.4% (64 calls)
+23.1%
stock +23% · XLRE +4%
matured Jan 2, 25
Stifel 
Nov 7, 23
▲ Buy · 🎯$16
Price at call : $13.85 — upside +16%
Today : $20.7 — upside -23%
Expected +16% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
+39.5%
stock +39% · XLRE +25%
matured Nov 6, 24
Wells Fargo 
Oct 17, 23
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $14.46 — gap to target +4%
Today : $20.7 — gap to target -28%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Oct 16, 24
BMO Capital 
Oct 17, 23
■ Market Perform neutral · not a buy · 🎯$16
Price at call : $14.6 — gap to target +10%
Today : $20.7 — gap to target -23%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 42.9% · +0.6% (42 calls)
in progress (365j)
matures : Oct 16, 24
Wells Fargo 
Oct 16, 23
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $14.56 — gap to target +3%
Today : $20.7 — gap to target -28%
🎯 on SBRA : no call matured yet · 📊 on Real estate : 51.5% · -0.1% (130 calls)
in progress (365j)
matures : Oct 15, 24
▲ Buy
Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 49.3% · +3.6% (71 calls)
+27.1%
stock +27% · XLRE +27%
matured Oct 9, 24
Wedbush 
Oct 3, 23
▲ Outperform · 🎯$16
Price at call : $13.5 — upside +19%
Today : $20.7 — upside -23%
Expected +19% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 100% (1 call matured) · 📊 on Real estate : 22.2% · -9.9% (18 calls)
+36.4%
stock +36% · XLRE +35%
matured Oct 2, 24
Jefferies 
Sep 20, 23
▲ Buy · 🎯$15
Price at call : $13.9 — upside +8%
Today : $20.7 — upside -28%
Expected +8% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+32.1%
stock +32% · XLRE +24%
matured Sep 19, 24
Stifel 
Feb 23, 22
▲ Buy · 🎯$18
Price at call : $13.01 — upside +38%
Today : $20.7 — upside -13%
Expected +38% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
-6.2%
stock -6% · XLRE -15%
matured Feb 23, 23
Stifel 
May 10, 21
▲ Buy · 🎯$21
Price at call : $17.78 — upside +18%
Today : $20.7 — upside +1%
Expected +18% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
-29.1%
stock -29% · XLRE -2%
matured May 10, 22
Jefferies 
Jan 13, 21
▲ Buy · 🎯$20
Price at call : $17.2 — upside +16%
Today : $20.7 — upside -3%
Expected +16% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
-17.6%
stock -18% · XLRE +37%
matured Jan 13, 22
Jefferies 
Aug 15, 17
▲ Buy
Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+7.4%
stock +7% · XLRE +3%
matured Aug 15, 18
Stifel 
Nov 4, 14
▲ Buy · 🎯$32
Price at call : $28.3 — upside +13%
Today : $20.7 — upside +55%
Expected +13% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
-26.0%
stock -26% · XLRE +3%
matured Nov 4, 15
Jefferies 
Aug 13, 14
▲ Buy · 🎯$32
Price at call : $27.73 — upside +15%
Today : $20.7 — upside +55%
Expected +15% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
-6.7%
stock -7% · XLRE +0%
matured Aug 13, 15
Stifel 
Feb 27, 14
▲ Buy · 🎯$31
Price at call : $28.25 — upside +10%
Today : $20.7 — upside +50%
Expected +10% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
+15.7%
stock +16% · XLRE +0%
matured Feb 27, 15
Stifel 
Jan 24, 14
▲ Buy · 🎯$30
Price at call : $28.47 — upside +5%
Today : $20.7 — upside +45%
Expected +5% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
+17.8%
stock +18% · XLRE +0%
matured Jan 24, 15
Stifel 
Jan 9, 14
▲ Buy · 🎯$29
Price at call : $26.27 — upside +10%
Today : $20.7 — upside +40%
Expected +10% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
+22.3%
stock +22% · XLRE +0%
matured Jan 9, 15
Jefferies 
Sep 18, 13
▲ Buy · 🎯$26
Price at call : $23.85 — upside +9%
Today : $20.7 — upside +26%
Expected +9% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+9.0%
stock +9% · XLRE +0%
matured Sep 18, 14
Stifel 
Aug 1, 13
▲ Buy · 🎯$30
Price at call : $25.19 — upside +19%
Today : $20.7 — upside +45%
Expected +19% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
+11.4%
stock +11% · XLRE +0%
matured Aug 1, 14
Stifel 
Jul 17, 13
▲ Buy · 🎯$32
Price at call : $27.77 — upside +15%
Today : $20.7 — upside +55%
Expected +15% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
+1.7%
stock +2% · XLRE +0%
matured Jul 17, 14
Stifel 
May 21, 13
▲ Buy · 🎯$34
Price at call : $31.94 — upside +6%
Today : $20.7 — upside +64%
Expected +6% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
-10.1%
stock -10% · XLRE +0%
matured May 21, 14
Stifel 
May 2, 13
▲ Buy · 🎯$31
Price at call : $30.53 — upside +2%
Today : $20.7 — upside +50%
Expected +2% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
-0.4%
stock -0% · XLRE +0%
matured May 2, 14
Jefferies 
Apr 3, 13
▲ Buy · 🎯$32
Price at call : $27.94 — upside +15%
Today : $20.7 — upside +55%
Expected +15% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+1.4%
stock +1% · XLRE +0%
matured Apr 3, 14
Stifel 
Mar 15, 13
▲ Buy · 🎯$30
Price at call : $27.5 — upside +9%
Today : $20.7 — upside +45%
Expected +9% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 50% (12 calls matureds) · 📊 on Real estate : 51.1% · +0.0% (94 calls)
-0.2%
stock -0% · XLRE +0%
matured Mar 15, 14
Jefferies 
Mar 4, 13
▲ Buy · 🎯$30
Price at call : $27.19 — upside +10%
Today : $20.7 — upside +45%
Expected +10% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+3.4%
stock +3% · XLRE +0%
matured Mar 4, 14
Jefferies 
Oct 17, 12
▲ Buy · 🎯$24
Price at call : $21.63 — upside +11%
Today : $20.7 — upside +16%
Expected +11% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+16.5%
stock +17% · XLRE +0%
matured Oct 17, 13
Jefferies 
Sep 25, 12
▲ Buy · 🎯$23
Price at call : $20.37 — upside +13%
Today : $20.7 — upside +11%
Expected +13% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+14.2%
stock +14% · XLRE +0%
matured Sep 25, 13
Jefferies 
Mar 2, 12
▲ Buy · 🎯$17
Price at call : $15.07 — upside +13%
Today : $20.7 — upside -18%
Expected +13% · Actual +80% · Reason (≥ +15%) : ✓ Yes
🎯 on SBRA : 80% (10 calls matureds) · 📊 on Real estate : 52.9% · +0.4% (70 calls)
+80.4%
stock +80% · XLRE +0%
matured Mar 2, 13

Frequently asked questions

Should I buy Sabra Health Care REIT stock?

This isn't buy advice. For Sabra Health Care REIT, the analyst consensus is "Hold", with an average price target of $22.00 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Sabra Health Care REIT). We show the numbers — you decide.

Is it too late to buy Sabra Health Care REIT? How high can it go?

The most bullish analyst target on Sabra Health Care REIT is $25.00 (+21% above today's price); the average is $22.00. That's the upside they see. Check how reliable those analysts have actually been on Sabra Health Care REIT on our site before trusting it.

Is Sabra Health Care REIT still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Sabra Health Care REIT, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Sabra Health Care REIT? The case for and against

The arguments for and against, one by one, from the numbers: why invest in SBRA (and why hesitate).

What has Sabra Health Care REIT's past performance been?

Historical returns and a "how much if I had invested" calculator: SBRA performance & returns.

Does Sabra Health Care REIT pay a dividend?

Yield, consistency and growth history of the dividend: SBRA's dividend.

What is the best month to buy SBRA?

The 12 months ranked by the stock's past returns: best & worst month to buy SBRA.

Other Real estate stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)